Pacific Biosciences IPO

Pacific Biosciences (PacBio) is a leading developer of sequencing systems that enable scientists and clinical researchers to improve their understanding of the genome through high-quality sequencing. The company's Single Molecule, Real-Time (SMRT) sequencing technology produces exceptionally long sequence reads with high accuracy, making it particularly valuable for applications like genome assembly, structural variant detection, and full-length transcript sequencing. PacBio's HiFi sequencing technology has become increasingly important for applications requiring highly accurate long reads, including human genome sequencing for medical research and agricultural genomics. The publicly traded company continues to compete with Illumina's short-read dominance and Oxford Nanopore's portable long-read systems by focusing on accuracy and specific use cases where long, accurate reads provide significant advantages.